Jak2 mutation expands the thrombophilic panel in children
Cerebral sinus venous thrombosis (CSVT) is an important cause of vascular accidents in children. The diagnosis of the underlying disease allows appropriate and timely management of the risk factors and guide therapy, but the etiology remains unknown in 20% to 25% of the cases. We present the first c...
Saved in:
Published in: | Journal of thrombosis and haemostasis Vol. 18; no. 10; pp. 2636 - 2639 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
Elsevier Limited
01-10-2020
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Cerebral sinus venous thrombosis (CSVT) is an important cause of vascular accidents in children. The diagnosis of the underlying disease allows appropriate and timely management of the risk factors and guide therapy, but the etiology remains unknown in 20% to 25% of the cases. We present the first case of a child presenting with CSVT caused by the Janus Kinase 2 (JAK2) V617F mutation, occurring without the hematological abnormalities diagnostic for myeloproliferative neoplasms. We therefore suggest including the molecular study of the JAK2 gene in the coagulation panel of all children affected by CSVT of unknown cause. |
---|---|
Bibliography: | : Manuscript handled by: David Lillicrap Final decision: David Lillicrap and 02‐Jul‐2020 Table of Contents Summary This first case of pediatric cerebral sinus venous thrombosis caused by JAK2 V617F mutation, without myeloproliferative neoplasm criteria, expands the thrombosis diagnostic panel for children. |
ISSN: | 1538-7933 1538-7836 1538-7836 |
DOI: | 10.1111/jth.14999 |